A. Sáenz

981 total citations
19 papers, 549 citations indexed

About

A. Sáenz is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, A. Sáenz has authored 19 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Rheumatology. Recurrent topics in A. Sáenz's work include Testicular diseases and treatments (9 papers), Urologic and reproductive health conditions (6 papers) and Bladder and Urothelial Cancer Treatments (2 papers). A. Sáenz is often cited by papers focused on Testicular diseases and treatments (9 papers), Urologic and reproductive health conditions (6 papers) and Bladder and Urothelial Cancer Treatments (2 papers). A. Sáenz collaborates with scholars based in Spain. A. Sáenz's co-authors include Joan Carles, Albert Font, Begoña Mellado, Xavier García del Muro, Jorge Aparicio, Josep Gumà, M. López-Brea, Pablo Maroto, R. Bastús and José Ángel Arranz and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

A. Sáenz

19 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Sáenz Spain	9	482	166	152	115	91	19	549
Elena Farè Italy	13	385 0.8×	111 0.7×	122 0.8×	113 1.0×	92 1.0×	42	482
Junji Irie Japan	12	228 0.5×	159 1.0×	77 0.5×	168 1.5×	100 1.1×	46	496
Kevin M. Kernek United States	8	312 0.6×	100 0.6×	185 1.2×	70 0.6×	64 0.7×	8	432
Tetsuo Itoh Japan	9	219 0.5×	103 0.6×	58 0.4×	71 0.6×	60 0.7×	17	472
Sidney Schultz United States	6	350 0.7×	180 1.1×	40 0.3×	160 1.4×	59 0.6×	12	488
P Lyn United States	7	406 0.8×	96 0.6×	42 0.3×	110 1.0×	163 1.8×	7	542
Geralyn Higgins United States	8	914 1.9×	251 1.5×	34 0.2×	271 2.4×	99 1.1×	10	996
Romeo A. Mandanas United States	10	226 0.5×	102 0.6×	27 0.2×	93 0.8×	64 0.7×	21	459
C Théodore France	11	178 0.4×	121 0.7×	30 0.2×	134 1.2×	77 0.8×	28	353
Dmitry Y. Baschinsky United States	12	193 0.4×	74 0.4×	76 0.5×	87 0.8×	42 0.5×	22	390

Countries citing papers authored by A. Sáenz

Since Specialization

Citations

This map shows the geographic impact of A. Sáenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Sáenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Sáenz more than expected).

Fields of papers citing papers by A. Sáenz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Sáenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Sáenz. The network helps show where A. Sáenz may publish in the future.

Co-authorship network of co-authors of A. Sáenz

This figure shows the co-authorship network connecting the top 25 collaborators of A. Sáenz. A scholar is included among the top collaborators of A. Sáenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Sáenz. A. Sáenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

González‐Billalabeitia, Enrique, Josep Gumà, Daniel Castellano, et al.. (2015). Prognostic significance of thromboembolic events in chemotherapy-treated germ cell tumors.. Journal of Clinical Oncology. 33(15_suppl). 4536–4536. 1 indexed citations

Gironés, Regina, Jorge Aparicio, J. R. Germa-Lluch, et al.. (2014). Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data base. Clinical & Translational Oncology. 16(11). 959–965. 15 indexed citations

Benavides, Manuel, Javier Gállego, Carmen Guillén‐Ponce, et al.. (2014). Gemcitabine(G)/erlotinib(E) versus gemcitabine/erlotinib/capecitabine(C) in the first-line treatment of patients with metastatic pancreatic cancer (mPC): Efficacy and safety results of a phase IIb randomized study from the Spanish TTD Collaborative Group.. Journal of Clinical Oncology. 32(15_suppl). 4122–4122. 5 indexed citations

Aparicio, Jorge, Regina Gironés, J. R. Germa-Lluch, et al.. (2013). Comparing diagnosis, management, and outcomes of synchronous versus metacrhonus brain metastases from testicular germ cell tumors (TGCT): Multinstitutional experience from the Spanish Germ Cell Cancer Group (SGCCG).. Journal of Clinical Oncology. 31(15_suppl). 4560–4560. 2 indexed citations

Rivera, Fernando, Maica Galán, Josep Tabernero, et al.. (2010). Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinoma. Cancer Chemotherapy and Pharmacology. 67(1). 75–82. 2 indexed citations

Rivera, Fernando, Maica Galán, Josep Tabernero, et al.. (2009). Phase II Trial of Preoperative Irinotecan–Cisplatin Followed by Concurrent Irinotecan–Cisplatin and Radiotherapy for Resectable Locally Advanced Gastric and Esophagogastric Junction Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 75(5). 1430–1436. 31 indexed citations

Aparicio, Jorge, J.R. Germà, Xavier García del Muro, et al.. (2005). Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study. Journal of Clinical Oncology. 23(34). 8717–8723. 134 indexed citations

Aparicio, Jorge, Xavier García del Muro, Pablo Maroto, et al.. (2004). Risk-adapted management of stage I seminoma: The second Spanish Germ Cell Cancer Group (GG) study. Journal of Clinical Oncology. 22(14_suppl). 4518–4518. 5 indexed citations

Andrés, Raquel, et al.. (2004). Predictive value of Serum S-100B protein in predicting relapse in patients with melanoma. Journal of Clinical Oncology. 22(14_suppl). 7532–7532. 1 indexed citations

10.

Aparicio, Jorge, Xavier García del Muro, Pablo Maroto, et al.. (2003). Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Annals of Oncology. 14(6). 867–872. 78 indexed citations

11.

Carles, Joan, A. Arriví, Óscar Juan, et al.. (2003). Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract. Cancer. 97(9). 2180–2186. 83 indexed citations

12.

Muro, Xavier García del, Pablo Maroto, A. Barnadas, et al.. (2003). 884 Long-term results following one course of adjuvant chemotherapy for high-risk stage I non-seminomatous germ cell tumors: the Spanish germ cell cancer group experience. European Journal of Cancer Supplements. 1(5). S266–S266. 1 indexed citations

13.

Marti, Juan Luis Gomez, José Mayordomo, Dolores Isla, et al.. (2001). Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines. Annals of Oncology. 12(8). 1061–1065. 15 indexed citations

14.

Muro, Xavier García del, Josep Gumà, Jorge Aparicio, et al.. (2001). E400P in advanced seminoma of good prognosis according to the International Germ Cell Cancer Collaborative Group (IGCCCG) classification: The Spanish Germ Cell Cancer Group experience. Annals of Oncology. 12(4). 487–491. 18 indexed citations

15.

Germà, J.R., Xavier García del Muro, Pablo Maroto, et al.. (2001). Patrón clínico y resultados terapéuticos obtenidos en el tumor germinal testicular en España a partir de una serie consecutiva de 1.250 pacientes. Medicina Clínica. 116(13). 481–486. 6 indexed citations

16.

Alonso, Vicente, P. Escudero, Dolores Isla, et al.. (2001). Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer. European Journal of Cancer. 37(18). 2385–2391. 13 indexed citations

17.

Bellmunt, Joaquim, Vicente Guillém, Luis Paz‐Ares, et al.. (2000). Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium. Journal of Clinical Oncology. 18(18). 3247–3255. 134 indexed citations

18.

Arranz, José Ángel, Xavier García del Muro, Josep Gumà, et al.. (1999). E400P in good prognosis advanced seminoma. The Spanish germ-cell cancer group experience. European Journal of Cancer. 35. S343–S343. 1 indexed citations

19.

Alonso, Vicente, Carmen Santander, Jesús Florián, et al.. (1996). Phase II Trial of Oral Tegafur and Folinic Acid with Mitoxantrone as First-Line Regimen in Patients with Metastatic Breast Cancer. Tumori Journal. 82(1). 61–64. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact